Across TCGA pan-cancer cohorts, RN7SKP172 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SKP172’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SKP172 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SKP172 is over-expressed in tumor.
LUAD and THCA are the cancer types where RN7SKP172 tumor–normal differential expression is most reproducible.